Transcranial Magnetic Stimulation
The three-day course offers intensive training on Transcranial Magnetic Stimulation (TMS). TMS is an FDA-cleared treatment for depression, obsessive-compulsive disorder, migraines and smoking cessation. This course is designed for psychiatrists, psychologists and researchers who wish to enhance their knowledge of TMS and related brain stimulation techniques, and includes didactic sessions and hands-on administration of TMS. The didactic sessions cover all topics relevant to running a TMS clinical service and a TMS research lab, including:
- Device principles and types; the neuroscience of TMS
- Motor threshold determination
- Treatment technique
- Stimulus dosing
- Risks, complications and contraindications
- Safety screening
- Post-TMS management and continuation treatment
- Clinical and non-clinical research applications
- Emerging brain stimulation techniques
Learning Objectives
- State the rationale for the use of TMS in depression, obsessive compulsive disorder and off-label conditions
-
Explain regulatory issues and policies concerning TMS
-
Name the two main components of transcranial magnetic stimulation devices
-
Operate the TMS device and correctly use it to determine the optimal site and motor threshold
-
Describe the findings from TMS research in imaging and motor cortex excitability studies
-
Apply the indications for use of TMS in depression
-
Identify the risks and side effects of TMS and describe how to conduct a safety screening
-
Design a protocol for seizure management during TMS administration
-
Outline steps necessary to set up a TMS service/lab
Schedule, Cost & Registration
The course, currently offered on a quarterly basis, is held on a Saturday from 8:30am to 5pm, Sunday from 8:30 am to 7pm and Monday from 8:30am to 5pm. Attendees must attend all three days of the course in order to receive full continuing education credit for the course.
The 2021 courses are being offered virtually due to COVID-19. The course dates are:
- January 23-25, 2021
- April 17-19, 2021
- July 17-19, 2021
- October 16-18, 2021
The cost of the course is $2,700 and the course is capped at 30 participants.
In Fall 2020, we conducted the first virtual version of the course. Learn more about and see photos of this successful virtual event!
Faculty
Greg Appelbaum, PhD
Dr. Appelbaum’ s research interests primarily concern neuroplasticity and learning using an assortment of human neuroscience techniques including electroencephalography (EEG), functional magnetic resonance imaging (fMRI), transcranial magnetic stimulation (TMS), and transcranial electrical stimulation (TES). This research is funded by the National Institutes of Health and the Department of Defense with the specific goal of translating basic science knowledge to applications that can improve human behavior and brain health.
Asa Cordle, MD
TMS Clinic Director
While at UNC-Chapel Hill for medical school and psychiatry residency, he trained in ECT and assisted with research in DBS and transcranial current stimulation. He then completed a fellowship at MUSC's Brain Stimulation Service, treating patients and supervising trainees in TMS and ECT. As a psychiatrist at Raleigh Psychiatric Associates, he has treated hundreds of patients with TMS as well as offered more conventional services to general psychiatry outpatients. In addition to neurostimulation, he also has interests in psychotherapy and longevity medicine and continues to train local colleagues in TMS He is excited about the continued progress seen with TMS and brain stimulation in complementing psychiatry's array of therapeutic approaches.
Simon W. Davis, PhD
Duke University School of Medicine
Leah D. Frymi, MD
Durham VA Medical Center
Following residency, she served as the medical director for the Carolina Center for Neurostimulation and interim medical director for the Clinical TMS Service while on the clinical faculty at University of North Carolina-Chapel Hill. In her current role as staff psychiatrist at the VA Medical Center in Durham, NC, she supervises Duke psychiatry residents and trainees while providing inpatient psychiatric and ECT services and working to expand veteran access to interventional treatments, including rTMS, infusions, and intranasal esketamine.
Tommy G. Fu, MD
Duke Electroconvulsive Therapy Clinic, Duke Regional Hospital
Duke University Hospital
He recently completed his general psychiatry residency at the Medical University of South Carolina in June 2020. During his last year of residency, he was fortunate enough to work extensively with the brain stimulation group at MUSC on clinical services. He also attended MUSC’s Brain Stimulation Intensive Course in 2019 directed by Dr. George. Dr. Fu is trained in both TMS and ECT. He is a member of the Clinical TMS Society.
Dr. Fu is a new faculty member in the Department of Psychiatry & Behavioral Sciences at Duke University School of Medicine/Duke Health. At Duke, his areas of clinical practice include inpatient psychiatry, outpatient psychiatry (student mental health and general adult), and electroconvulsive therapy.
Colleen A. Hanlon, PhD
Department of Cancer Biology at Wake Forest University Health Sciences
She participates in the research training and education community at both a local level (serving as a mentor to over 50 medical, graduate, post-graduate, and fellowship trainees since 2005 on a national and international scale) and national level. She has directed the Advanced TMS Training Course sponsored by the National Center for Neuromodulation for Rehabilitation, and continues to be involved in their research dissemination efforts through teaching and management of their social media presence. She has led an annual addiction outreach event at the College of Problems on Drug Dependence (CPDD) meeting (2015-2019), served on the Liaison Committee (2016-2019) and the Education and Training Committee (2019-present) for the American College of Neuropsychopharmacology, Grassroots Advocacy Team for the Society for Neuroscience (2017-2019), Chair of the Education Outreach and Public Policy Committee for CPDD (2017-2019), ad hoc participation in over 20 NIH study sections, and serving as a standing member of NIH NPAS study section (effective 10/2018).
Bruce M. Luber, PhD
Shawn M. McClintock, PhD, MSCS
Division of Psychology, Department of Psychiatry
UT Southwestern Medical Center
Department of Psychiatry & Behavioral Sciences
Andrada D. Neacsiu, PhD
Director of Behavioral Medicine
Department of Psychiatry & Behavioral Sciences
Department of Family Medicine and Community Health
Duke University Medical Center
As an educator, she trains clinicians nationally and teaches Duke graduate students, psychology and psychiatry residents in in how to effectively apply CBT and DBT in their clinical work. She also directs a wellness program in the department of Family Medicine and Community Health.
As a researcher, she focuses on psychotherapy optimization and neuroscience-informed treatment development for emotion dysregulation. Her research keeps her up to date with the latest evidence-based approaches to use in her clinical work, and her work with patients strongly influences the research that she does. Outside of work, she enjoys traveling, gourmet food, nature adventures and time with friends and family.
Angel V. Peterchev, PhD
Division of Behavioral Medicine & Neurosciences
Departments of Biomedical Engineering, Electrical & Computer Engineering, and Neurosurgery (secondary)
Duke University
Sandeep Vaishnavi, MD, PhD
Program and Medical Director, MindPath Care Centers Clinical Research Institute
Ellie Wood
Department of Psychiatry & Behavioral Sciences, Division of Behavioral Medicine and Neurosciences
Duke University School of Medicine
Jonathan R. Young, MD
Research Fellow, Duke Clinical Research Institute (DCRI)
Clinical Associate, Division of Behavioral Medicine & Neurosciences
Department of Psychiatry & Behavioral Sciences
Duke University School of Medicine
Planning Committee/Faculty Disclosure
The following speakers and/or planning committee members have indicated they have no relationship(s) with industry to disclose relative to the content of this CME activity:
- Lawrence Appelbaum, PhD
- Asa Cordle, MD
- Simon Davis, PhD
- Tommy Fu, MD
- Sarah H. Lisanby, MD
- Bruce Luber, PhD
- Marisa Spurrell, BA
- Jonathan Young, MD
The following speaker/planning committee member have indicated that s/he has relationship(s) with industry to disclose:
- Stefan Goetz, PhD, investigator for Magstim. Stock holder in Nervive.
- Colleen A. Hanlon, PhD, consultant for Roswell Park Cancer Institute.
- Shawn M. McClintock, PhD, MSCS, consultant for X-Pearson Assessment.
- Andrada Neacsiu, PhD, has received training fees for teaching mental health providers cognitive behavioral therapy and dialectical behavioral therapy techniques from Behavioral Tech and NC AHECs.
- Angel V. Peterchev, PhD, is inventor on patents and patent applications and has received research and travel support as well as patent royalties from Rogue Research, research and travel support, consulting fees, as well as equipment loan from Tal medical, patent application support from Magstim, as well as equipment loans from MagVenture, all related to technology for TMS.
- Sandeep Vaishnavi, MD, PhD, employee of MindPath Care Centers, primary investigator for Otsuka, primary investigator for National Institute of Child Health and Human Development, and consultant for the Department of Defense.
Disclaimer
The information provided at this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.
Statements by industry representatives during the industry device demos and exhibits may not reflect the views and opinions of the course organizers and faculty.
Credit Designation
Accreditation Statement
Contact Us